MARIAM MIKELADZE: Open Payments
NPI 1740583509 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,192 in 108 payments from 32 companies in 2025. Trend: 2023 $1,913 · 2024 $2,519 · 2025 $2,192
Food & beverage: $2,192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $306 |
| AstraZeneca Pharmaceuticals LP | 4 | $206 |
| Lilly USA, LLC | 8 | $167 |
| Amgen Inc. | 12 | $154 |
| PFIZER INC. | 8 | $150 |
| GlaxoSmithKline, LLC. | 7 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
| Novo Nordisk Inc | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $88 |
| Abbott Laboratories | 4 | $82 |
Products named: VRAYLAR, AIRSUPRA, JARDIANCE, NURTEC ODT, TRELEGY ELLIPTA, Kerendia, FREESTYLE LIBRE 3, EVENITY.
Industry payments across CO — which companies pay providers there.
